Pharmacological treatments  of mood and anxiety disorders
Monoamine reuptake inhibitors
Benzodiazepine
BUT…
• Delayet onset of therapeutic action
• Significant non-responsive patients
• Adverse side-effects
Ø nausea, sexual dysfunction, sweating…)  with monoamine reuptake inhibitors
Ø sedation, cognitive impairment and dependence with benzodiazepine
Ø
NOVEL TREATMENT APPROACHES ~ NEUROPEPTIDES
NEUROPEPTIDE SYSTEMS AS NOVEL THERAPEUTIC TARGETS FOR DEPRESSION AND ANXIETY DISORDERS